Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088572321> ?p ?o ?g. }
- W2088572321 endingPage "1423" @default.
- W2088572321 startingPage "1419" @default.
- W2088572321 abstract "Growing evidence has indicated that the blockade of group II metabotropic glutamate (mGlu2/3) receptor exerts antidepressant-like effects in several animal models of depression. However, the molecular mechanisms underlying the action of mGlu2/3 receptor antagonists are not well understood. Here, we investigated the involvement of mammalian target of rapamycin (mTOR) signaling in the acute and sustained antidepressant-like effects of mGlu2/3 receptor antagonists such as (1R, 2R, 3R, 5R, 6R)-2-amino-3-(3,4-dichlorobenzyloxy)-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039) and (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495). Mice were subjected to a tail suspension test (TST) to assess the acute and sustained antidepressant-like effects. We evaluated the effect of rapamycin, an mTOR antagonist, on the acute and sustained antidepressant-like effects of mGlu2/3 receptor antagonists. Both MGS0039 and LY341495 exerted antidepressant-like effects, as evaluated using the TST; these effects were sustained for 24 h. Pretreatment with rapamycin blocked the sustained, but not the acute, antidepressant-like effects of mGlu2/3 receptor antagonists, as observed in ketamine. The present result suggests that the blockade of the mGlu2/3 receptor may activate mTOR signaling, and that the activation of mTOR signaling may contribute to the sustained antidepressant-like effects of mGlu2/3 receptor antagonists." @default.
- W2088572321 created "2016-06-24" @default.
- W2088572321 creator A5039021133 @default.
- W2088572321 creator A5063039861 @default.
- W2088572321 creator A5070242945 @default.
- W2088572321 date "2011-12-01" @default.
- W2088572321 modified "2023-10-16" @default.
- W2088572321 title "Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists" @default.
- W2088572321 cites W1964790038 @default.
- W2088572321 cites W1968311418 @default.
- W2088572321 cites W1970078705 @default.
- W2088572321 cites W1970840966 @default.
- W2088572321 cites W1976392245 @default.
- W2088572321 cites W1997113206 @default.
- W2088572321 cites W1999259477 @default.
- W2088572321 cites W2005594217 @default.
- W2088572321 cites W2007334584 @default.
- W2088572321 cites W2010734130 @default.
- W2088572321 cites W2020948229 @default.
- W2088572321 cites W2023081218 @default.
- W2088572321 cites W2031231313 @default.
- W2088572321 cites W2032739515 @default.
- W2088572321 cites W2046822015 @default.
- W2088572321 cites W2052617026 @default.
- W2088572321 cites W2074907255 @default.
- W2088572321 cites W2081351662 @default.
- W2088572321 cites W2087002084 @default.
- W2088572321 cites W2089351762 @default.
- W2088572321 cites W2108212317 @default.
- W2088572321 cites W2109334244 @default.
- W2088572321 cites W2145936409 @default.
- W2088572321 doi "https://doi.org/10.1016/j.neuropharm.2011.08.034" @default.
- W2088572321 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21903115" @default.
- W2088572321 hasPublicationYear "2011" @default.
- W2088572321 type Work @default.
- W2088572321 sameAs 2088572321 @default.
- W2088572321 citedByCount "101" @default.
- W2088572321 countsByYear W20885723212012 @default.
- W2088572321 countsByYear W20885723212013 @default.
- W2088572321 countsByYear W20885723212014 @default.
- W2088572321 countsByYear W20885723212015 @default.
- W2088572321 countsByYear W20885723212016 @default.
- W2088572321 countsByYear W20885723212017 @default.
- W2088572321 countsByYear W20885723212018 @default.
- W2088572321 countsByYear W20885723212019 @default.
- W2088572321 countsByYear W20885723212020 @default.
- W2088572321 countsByYear W20885723212021 @default.
- W2088572321 countsByYear W20885723212022 @default.
- W2088572321 countsByYear W20885723212023 @default.
- W2088572321 crossrefType "journal-article" @default.
- W2088572321 hasAuthorship W2088572321A5039021133 @default.
- W2088572321 hasAuthorship W2088572321A5063039861 @default.
- W2088572321 hasAuthorship W2088572321A5070242945 @default.
- W2088572321 hasConcept C119128870 @default.
- W2088572321 hasConcept C126322002 @default.
- W2088572321 hasConcept C136569192 @default.
- W2088572321 hasConcept C170493617 @default.
- W2088572321 hasConcept C185592680 @default.
- W2088572321 hasConcept C26702167 @default.
- W2088572321 hasConcept C2776885963 @default.
- W2088572321 hasConcept C2778875871 @default.
- W2088572321 hasConcept C2779177272 @default.
- W2088572321 hasConcept C2781001258 @default.
- W2088572321 hasConcept C2781161787 @default.
- W2088572321 hasConcept C41653306 @default.
- W2088572321 hasConcept C49051014 @default.
- W2088572321 hasConcept C55493867 @default.
- W2088572321 hasConcept C61174792 @default.
- W2088572321 hasConcept C62478195 @default.
- W2088572321 hasConcept C71924100 @default.
- W2088572321 hasConcept C86554907 @default.
- W2088572321 hasConcept C98274493 @default.
- W2088572321 hasConceptScore W2088572321C119128870 @default.
- W2088572321 hasConceptScore W2088572321C126322002 @default.
- W2088572321 hasConceptScore W2088572321C136569192 @default.
- W2088572321 hasConceptScore W2088572321C170493617 @default.
- W2088572321 hasConceptScore W2088572321C185592680 @default.
- W2088572321 hasConceptScore W2088572321C26702167 @default.
- W2088572321 hasConceptScore W2088572321C2776885963 @default.
- W2088572321 hasConceptScore W2088572321C2778875871 @default.
- W2088572321 hasConceptScore W2088572321C2779177272 @default.
- W2088572321 hasConceptScore W2088572321C2781001258 @default.
- W2088572321 hasConceptScore W2088572321C2781161787 @default.
- W2088572321 hasConceptScore W2088572321C41653306 @default.
- W2088572321 hasConceptScore W2088572321C49051014 @default.
- W2088572321 hasConceptScore W2088572321C55493867 @default.
- W2088572321 hasConceptScore W2088572321C61174792 @default.
- W2088572321 hasConceptScore W2088572321C62478195 @default.
- W2088572321 hasConceptScore W2088572321C71924100 @default.
- W2088572321 hasConceptScore W2088572321C86554907 @default.
- W2088572321 hasConceptScore W2088572321C98274493 @default.
- W2088572321 hasIssue "8" @default.
- W2088572321 hasLocation W20885723211 @default.
- W2088572321 hasLocation W20885723212 @default.
- W2088572321 hasOpenAccess W2088572321 @default.
- W2088572321 hasPrimaryLocation W20885723211 @default.
- W2088572321 hasRelatedWork W1997113206 @default.
- W2088572321 hasRelatedWork W2019658937 @default.